Post-operative infection of endoscopic submucosal dissection of early colorectal neoplasms: a case?controlled study using a Japanese database by Muro Takahiro et al.
1 
Postoperative infection of endoscopic submucosal dissection of early colorectal 
neoplasms: a case controlled-study using a Japanese database 
 
Takahiro Muro* PhD, Norihide Higuchi* PhD, Masanobu Imamura* PhD, Hiroo 
Nakagawa* PhD, Masayuki Honda† PhD, Kazuhiko Nakao‡ MD PhD, Koichi 
Izumikawa§, MD PhD, Hitoshi Sasaki* PhD, Takashi Kitahara* PhD 
*Department of Clinical Pharmacy, Nagasaki University Hospital, †Department of 
Medical Information, Nagasaki University Hospital, ‡Department of Gastroenterology 
and Hepatology, Nagasaki University Hospital, § Infection Control and Education 
Center, Nagasaki University Hospital. 
 
Address correspondence to: Takahiro Muro 
Department of Clinical Pharmacy, Nagasaki University Hospital 
1-7-1 Sakamoto, Nagasaki, Nagasaki, 852-8501, Japan 
E-mail: muroth1@nagasaki-u.ac.jp 
TEL +81-95-819-7249 FAX +81-95-819-7251 
 
Keywords: Antibiotic Prophylaxis, Surgical Wound Infection, Pharmacoepidemiology 
2 
SUMMARY 
What is known and objective: Endoscopic submucosal dissection of early colorectal 
neoplasms (ESD - ECN) is known to be an operation with risk of contamination, possibly 
requiring preoperative antimicrobial prophylaxis for prevention of postoperative infection. 
However, an evaluation of the need for preoperative antimicrobial prophylaxis of ESD – 
ECN has yet to be reported. The objective of this study was to determine whether 
preoperative antimicrobial prophylaxis is associated with a reduced incidence of 
postoperative infection following ESD - ECN. 
Methods: The present retrospective case-controlled study utilized a database built from 
the medical records of 14 university hospitals throughout Japan. Patients who were 
admitted and discharged from the hospital from April 2012 to October 2013 and who had 
undergone ESD - ECN were included in the study. Patients who had been undergone any 
other operation during their course of hospitalization, and patients who were prescribed 
antimicrobial agents for reasons other than postoperative infection or for prophylaxis 
were excluded. Characteristics of the study population, preoperative antimicrobial 
prophylaxis, and antimicrobial therapy for postoperative infection were investigated. In 
addition, we compared the characteristics of patients with postoperative infection (PI) and 
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those with no postoperative infection (NPI). Univariate analyses were used to estimate 
the odds ratios (OR) and 95% confidence intervals (95%CI). 
Results and discussion: We obtained the records of 522 patients who had undergone ESD 
- ECN from the database. After application of exclusion criteria, 421 patients were 
enrolled. The postoperative infection rate was 1.2%. Peritonitis was found most to be the 
most common postoperative infection (44%). Preoperative antimicrobial prophylaxis was 
used for 314 patients (75%), with a median duration of 3.0 (range 1 – 11) days. Cefotiam 
was most frequently prescribed for preoperative antimicrobial prophylaxis (56%). 
Antimicrobial therapies were started 1 to 10 days after ESD - ECN for a duration of 1 to 
14 days. Preoperative antimicrobial prophylaxis was not associated with postoperative 
infection rate, with an OR (95%CI) of 0.73 (0.08 – 6.61). However, digestive tract 
perforation was shown to be associated with postoperative infection, and had an OR 
(95%CI) of 17.1 (1.66-176.45). 
What is new and conclusion: Postoperative infection is an exceedingly rare event 
following ESD - ECN. Preoperative antimicrobial prophylaxis had no significant effect 
on postoperative infection following ESD - ECN, and thus may be unnecessary. Instead, 
prevention of digestive tract perforation may be more critical for the decrease in 
postoperative infections. 
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What is known and objective 
Endoscopic submucosal dissection (ESD) is a variant of endoscopic mucosal resection 
(EMR), and is a technique for resection of early gastrointestinal tract cancers. ESD is used 
primarily in the stomach, but is also increasingly being applied in the colon and rectum1, 
2). The technique involves identifying the margins of the polyp, submucosal injection, and 
circumferential dissection of the tumor-bearing mucosa and submucosa using various 
diathermic knives. The aim of ESD is to achieve an en-bloc resection of a sessile lesion, 
irrespective of its size. This facilitates histological evaluation and improves the rate of 
curative resection, even for carcinomas with early submucosal invasion3).  
Postoperative infections are a major contributor to healthcare-associated infections. 
Gastrointestinal procedures are thought to have the highest risk for postoperative 
infection due to exposure to intraluminal bacteria4). Therefore, preoperative antimicrobial 
prophylaxis is warranted for patients undergoing gastrointestinal surgery involving the 
colon or rectum. ESD of early colorectal neoplasms (ESD - ECN) is considered to be an 
operation with risk of contamination, possibly requiring preoperative antimicrobial 
prophylaxis for the prevention of postoperative infection. Because the ESD procedure 
requires advanced skill and extensive training to achieve a satisfactory level of ability, the 
use of this technique has been somewhat limited. Therefore, the evaluation of the need 
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for preoperative antimicrobial prophylaxis for ESD has not been sufficient. The objective 
of this study was to determine if preoperative antimicrobial prophylaxis is associated with 
a reduced incidence of postoperative infection following ESD - ECN. 
 
Methods 
Study Design and Data Source 
This study was a retrospective case-controlled study utilizing the Platform for Clinical 
Information Statistical Analysis (CISA) database, which is composed of clinical data 
from 14 university hospitals throughout Japan. The CISA database contains data on 
approximately 2.45 million unique patients, a cumulative total of 1.25 million inpatients, 
a cumulative total of 37.79 million outpatients, 32.86 million prescriptions for inpatients, 
and 14.50 million prescriptions for outpatients. These data were collected from the 
medical records from each facility after removing personal information and irreversibly 
anonymizing the data. At present, data on medical treatment results, such as test results 
and interviews, information on palpation, and images are not included in the database. 
Diagnostic codes were established according to both the International Statistical 
Classification of Diseases and Related Health Problems 10th Revision (ICD-10) and the 
Japanese Receipt Disease Name Master (JRDNM). Drug codes were established 
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according to the Anatomical Therapeutic Chemical Classification System (ATC) code. In 
the present study, only data obtained from April 2012 to October 2013 were analyzed. 
Population and Definitions 
Data on patients who were admitted and discharged from the hospital from April 2012 to 
October 2013 and who had undergone ESD - ECN were collected from the CISA database. 
To reduce any possible influence of the patients’ preoperative conditions, patients who 
had undergone ESD - ECN more than 4 days after the date of admission were excluded. 
Four days was selected because this duration was the most generally period from 
hospitalization to do ESD – ECN in Japan. Patients who had undergone any other 
operation other than their first ESD – ECN procedure during their course of 
hospitalization, such as those who had undergone additional tumorectomy or ESD for the 
same or different region, were also excluded. Patients who were prescribed antimicrobial 
agents for treatment of conditions other than postoperative infection were excluded, as 
were patients who were prescribed antimicrobial agents for purposes other than 
postoperative infection or prophylaxis. The patients remaining after application of the 
exclusion criteria was divided into two groups, those who had been postoperative 
infection (PI) and those who had been not PI (NPI) (Fig. 1). 
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Codes from the Japanese Receipt Disease Name Master were used for definition of 
postoperative infection. Codes for infectious diseases were selected by excluding 
infections originating from regions other than the abdomen, such as pneumonia, from all 
disease codes of the study population, and defined the remaining as Postoperative 
Infection Codes (PIC). In the present study, antimicrobial therapy for postoperative 
infection was defined as antimicrobial therapy administered to patients who were 
assigned a PIC after undergoing ESD - ECN. Thus, the postoperative infection group (PI) 
was defined as patients who were treated with antimicrobial therapy for postoperative 
infection. 
Preoperative antimicrobial prophylaxis was defined as antibiotic administration during 
the first day of hospitalization to the day of ESD - ECN. 
Epidemiological Research and Statistical Methods 
Characteristics of the study population, use of preoperative antimicrobial prophylaxis, 
and administration of antimicrobial therapy for postoperative infection were collected 
from the database for epidemiological evaluation. JRDNM were used for definition of the 
perforation of the digestive tract. Perforation of the digestive tract was defined as patients 
who were assigned JRDNM codes that were meaning "perforation of the digestive tract" 
in the disease name after undergoing ESD – ECN and counted. Additionally, the duration 
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of hospitalization after ESD – ECN, and the number of patients with malignant tumor-
related diseases were collected for comparison between the PI and NPI groups. We 
compared the PI and NPI groups using the Wilcoxon rank sum test for continuous 
variables, the chi-square, or Fisher’s exact test for dichotomous variables. Differences 
were considered significant when P < 0.05. Univariate analyses was used to determine 
independent predictors of postoperative infection and to obtain odds ratios (OR), and the 
95% confidence interval (95%CI) for each OR was calculated. Statistical significance 
was determined by 95% confidence intervals, not including 1.00 for logistic analyses. We 
introduced preoperative antimicrobial prophylaxis and digestive tract perforations as 
groups of variables into the model, because these are well known to be associated with 
postoperative infection. 
Ethics statement 
Because the data utilized in this study were provided to us already anonymized by the 
database provider, CISA, the study was exempted from obtaining informed consent from 
individual patients according to the local ethical guidelines for epidemiological research. 
This study and the waiver of informed consent were approved by the Nagasaki University 
Hospital ethics committee (14102796). 
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Results and discussion 
1. Characteristics of the study population: 
We obtained data on 522 patients who had undergone ESD - ECN from the CISA database. 
After applying the exclusion criteria, 421 patients were enrolled in the present study 
(Figure 1). The postoperative infection rate was 1.2%. Types of neoplasms observed in 
the study population are shown in Table 1. The majority of the patients had malignant 
neoplasms of the colon (45%) or rectum (14%). Perforation of the digestive tract was 
observed in 2% of patients. The characteristics of postoperative infection of the study 
population are shown in Table 2. Peritonitis (including generalized, circumscribed, and 
perforative peritonitis) were the most common postoperative infection (44%). Only two 
cases were reported to have developed sepsis (0.5%). 
2. Characteristics of preoperative antimicrobial prophylaxis: 
Preoperative antimicrobial prophylaxis was used for 314 patients (75%). The median 
dosing period of preoperative antimicrobial prophylaxis was 3.0 (range 1 – 11) days. 
Table 3 shows the duration of the preoperative antimicrobial prophylaxis per generic 
name. Cefotiam was the most commonly prescribed preoperative antimicrobial 
prophylaxis (56%), with a median dosing period of 3.0 days. Cefmetazole were the 
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second most frequently prescribed prophylaxis (17%), with a median dosing period of 2.5 
days. 
3. Antimicrobial therapy for postoperative infection: 
The median duration of antimicrobial therapy for postoperative infection was 4 days; the 
characteristics are shown in Table 4. Six agents, including combination therapy, were used 
for treatment of postoperative infection, and were started 1 to 10 days after ESD - ECN 
for a duration of 1 to 14 days. 
4. Comparison of the PI and NPI groups: 
Characteristics of the PI and NPI groups are shown in Table 5, with no significant 
differences between the two groups. Table 6 shows the duration of the preoperative 
antimicrobial prophylaxis per generic name of PI. Cefotiam was the most commonly 
prescribed preoperative antimicrobial prophylaxis (50%) of PI, too. Univariate analyses 
of PI and NPI is shown in Table 7. Preoperative antimicrobial prophylaxis was not 
associated with postoperative infection, and had an OR (95%CI) of 0.73 (0.08 – 6.61). 
However, perforation of the digestive tract was associated with postoperative infection, 
and had an OR (95%CI) of 17.1 (1.66-176.45). 
The present results suggested that there is no significant correlation between preoperative 
antimicrobial prophylaxis and incidence of postoperative infection after ESD - ECN. 
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Instead, perforation of the digestive tract was found to increase postoperative infection 
approximately 17-fold. In present study, it is not possible to perform multivariate logistic 
regression analysis, because the low number of patients with postoperative infection. So 
we conducted univariate analyses. Therefore, our results may include the confounding 
factors. 
The postoperative infection rate in the present study was 1.2%, and was lower than that 
rate previously reported for whole colon surgery (15%)5). Sepsis had developed in only 2 
patients (0.5%). Similarly, Minn et al. reported a low bacteremia rate (2.5%) associated 
with ESD or endoscopic mucosal resection (EMR) 6), suggesting that this was due to the 
low possibility of direct injection into a blood vessel during submucosal injection6). This 
may also be the case in ESD, which is usually used for resecting a large lesion, and 
consequently results in a considerable amount of exposed submucosa, requiring a large 
number of submucosal injections. Therefore, ESD may have a higher risk for 
postoperative infection than EMR. However, ESD has considerably fewer opportunities 
of injury to blood vessels compared with general colon surgery. Unlike an open abdominal 
surgery, ESD does not remove the digestive tract, and does not spill bacteria-laden 
intestinal contents into the abdomen. Supporting this, the present study found that 
perforation of the digestive tract was an important contributor to postoperative infection. 
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The reduced incidence in spilling bacteria-laden intestinal contents into the abdomen may 
contribute to the lower postoperative infection rate of ESD. The use of second-generation 
cephalosporin (cefoxitin or cefotetan) or cefazolin plus metronidazole is recommended 
as intravenous antimicrobial prophylaxis for colorectal surgery4, 7). In the present study, 
76% of preoperative antimicrobial prophylaxes were second-generation cephalosporin, 
and the selection of antibiotics used in the study population was shown to be reasonable. 
On the other hand, the median duration of antimicrobial prophylaxis was 3.0 (range 1 – 
11) days, which was longer than the reported 24-hour duration used in common practice8). 
Nelson et al. reported that there was no need for a second intraoperative dose, or any 
postoperative doses, when the antibiotic was used for the purpose of prophylaxis of ESD 
or EMR6). However, Japanese guidelines on the management of infectious diseases has 
reported that antimicrobial prophylaxis for a duration of 2 days was acceptable, but over 
3 days increased the risk of infection with antimicrobial resistant bacteria9). Therefore, 
these results suggested overall adherence to the Japanese guidelines for antimicrobial 
prophylaxis duration. Nearly all antimicrobial agents used for postoperative infection 
were those selective for anaerobic bacteria. Whether these choices in antibiotics were 
optimal cannot be determined with confidence due to the lack of cultivation test results 
in the database, and is one of the limitations of the present study. Furthermore, the present 
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study was unable to assess treatment result data, such as interviews and palpation 
information, nor were images available for investigation. Therefore, postoperative 
infection was defined in a two-step process, first identifying those patients diagnosed with 
an infectious disease obtained from the case records and then identifying those who were 
prescribed an antibiotic.  
 
What is new and conclusion 
Postoperative infection is an exceedingly rare event following ESD - ECN. Preoperative 
antimicrobial prophylaxis had no significant effect on postoperative infection following 
ESD - ECN, and thus may be unnecessary. On the other hand, the prevention of digestive 
tract perforation is important for decreasing the incidence of postoperative infection. 
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Endoscopic submucosal dissection of early colorectal neoplasms (ESD - ECN) (n = 522)
Postoperative infection group (PI) ( n = 5)
No - postoperative infection group (NPI) ( n = 416)
Figure 1 Flow chart for selection of study population
ESD - ECN was performed more than 4 days after date of admission (n = 61)
Patients who had undergone operations other than ESD - ECN
(including additional tumorectomy or ESD for the same or different region) (n = 13)
Patients who were prescribed antimicrobial agents for purposes other than postoperative
infection or prophylaxis (n = 27)
ICD10 code Description
C18 Malignant neoplasm of colon 347 ( 45 )
C20 Malignant neoplasm of rectum 109 ( 14 )
C78 Secondary malignant neoplasm of respiratory and digestive organs 52 ( 7 )
C16 Malignant neoplasm of stomach 47 ( 6 )
C34 Malignant neoplasm of bronchus and lung 32 ( 4 )
C25 Malignant neoplasm of pancreas 24 ( 3 )
C79 Secondary malignant neoplasm of other and unspecified sites 19 ( 2 )
C22 Malignant neoplasm of liver and intrahepatic bile ducts 18 ( 2 )
C61 Malignant neoplasm of prostate 14 ( 2 )
C67 Malignant neoplasm of bladder 11 ( 1 )
C80 Malignant neoplasm, without specification of site 10 ( 1 )
C15 Malignant neoplasm of oesophagus 9 ( 1 )
C50 Malignant neoplasm of breast 8 ( 1 )
C91 Lymphoid leukaemia 8 ( 1 )
C77 Secondary and unspecified malignant neoplasm of lymph nodes 7 ( 1 )
C85 Other and unspecified types of non-Hodgkin lymphoma 6 ( 1 )
C19 Malignant neoplasm of rectosigmoid junction 4 ( 1 )
Others 41 ( 5 )
ICD10: International Statistical Classification of Diseases and Related Health Problems 10th revision
Including multiple primaries and metastases
Table 1 Patient neoplasms
n (%)
PIC number* Postoperative infection† n
389004 sepsis 2
8833267 diarrheal disease 2
91023 enteritis 1
5679005 generalized peritonitis 1
5679007 circumscribed peritonitis 1
5679012 perforative peritonitis 1
5679015 peritonitis 1
*: Japanese Receipt Disease Name Master was used for the definition
of postoperative infection.
†:  Codes for infectious diseases were selected by excluding infections
originating from regions other than the abdomen, such as pneumonia,
from all disease codes of the study population, and defined the
remaining as Postoperative Infection Codes (PIC).
Includes complex infections.
Table 2 Postoperative infections
Cefotiam 182 ( 56 ) 3.0 ( 1 - 7 )
Cefmetazole 56 ( 17 ) 2.5 ( 1 - 11 )
Ampicillin and enzyme inhibitor 46 ( 14 ) 3.0 ( 1 - 7 )
Meropenem 10 ( 3 ) 5.0 ( 4 - 6 )
Cefazolin 10 ( 3 ) 3.0 ( 1 - 3 )
Flomoxef 8 ( 2 ) 2.0 ( 2 - 4 )
Ceftriaxone 7 ( 2 ) 3.0 ( 1 - 9 )
Cefoperazone, combination 5 ( 2 ) 3.0 ( 2 - 9 )
Clindamycin 1 ( 0 ) 4.0 ( - )
Table 3 Preoperative antimicrobial prophylaxis
ATC: Anatomical Therapeutic Chemical Classification System
Duration (d),
median (range)ATC level5 name n* ( )%
*: including combination therapy






Sulfamethoxazole and trimethoprim 1 7 2
Metronidazole 1 4 14
Doripenem 1 5 4
Cefazolin 1 2 1
Piperacillin and enzyme inhibitor 1 10 5
Cefmetazole 1 1 4
*: including combination therapy
ATC: Anatomical Therapeutic Chemical Classification System
Table 4 Antimicrobial therapy for postoperative infection
PI NPI P value
5 416 -
73 (54 - 87)68 (54 - 92) 0.72
8 (5 - 22) 6 (3 - 20) 0.03





















2 3 (60) 135 (11)
3 1 (20) 44 (7)
4 29 (4)
5 16 (4)
> 5 1 (20) 40 (10)
4 (80) 310 (75) 0.81
5 (2 - 9) 3 (1 - 11) 0.07
PI: postoperative infection group; NPI: no postoperative infection group;
Table 5 Characteristics of the PI and NPI groups
Number of malignant tumor-related diseases  n (%)
Male n (%)
N
Age (y), median (range)
Duration of  stay after ESD (d), median (range)
Classification of Diseases*
Infectious and parasitic diseases    
Neoplasms    
Endocrine, nutritional, and metabolic diseases    
Mental and behavioral disorders    
Diseases of the nervous system    
Factors influencing health status and contact with health services    
Diseases of the blood and blood-forming organs and disorders
involving the immune system
Injury, poisoning, and other consequences of external causes    
4
Duration of preoperative antimicrobial prophylaxis (d), median
Preoperative antimicrobial prophylaxis n (%)
5
*; International Statistical Classification of Diseases and Related Health Problems 10th revision (ICD-10)
code, including overlap
†; Patients whose abnormal tissue samples were found to be not cancerous after postoperative pathological
examination
We compared the baseline characteristics of the PI and NPI groups using the Wilcoxon rank sum test for
continuous variables, the Yates’ chi-square, or Fisher’s exact test for discrete variables.
144Symptoms, signs, and abnormal clinical and laboratory findings, notelsewhere classified
108
Diseases of the genitourinary system    
Pregnancy, childbirth, and the puerperium    
Congenital malformations, deformations, and chromosomal abnorma     
Diseases of the circulatory system    
Diseases of the respiratory system    
Diseases of the digestive system    
Diseases of the skin and subcutaneous tissue    
Diseases of the eye and adnexa    
Diseases of the ear and mastoid process    
Diseases of the musculoskeletal system and connective tissue    
Cefotiam 2 ( 50 ) 5.0 ( 5 - 5 )
Cefmetazole 1 ( 25 ) 2.0 ( - )
Cefoperazone, combination 1 ( 25 ) 9.0 ( - )
Table 6 Preoperative antimicrobial prophylaxis of PI
ATC level5 name n ( % ) Duration (d),median (range)
PI NPI OR 95% CI
Preoperative antimicrobial prophylaxis n, (%) 4 (80) 310 (75) 0.73 0.08-6.61
Perforation of the digestive tract n, (%) 1 (20) 6 (1) 17.1 1.66-176.45
Table 7  Univariate analyses of PI versus NPI
PI: postoperative infection group; NPI: no postoperative infection group;
OR: Odds ratios; 95%CI: 95% confidence interval
